GSK-SCO30003

Study Sponsor: GSK

Study Title

A multicentre, randomised, double-blind, parallel group, placebo-controlled study to investigate the long-term effects of salmeterol/fluticasone propionate (SERETIDE® inhaler) 50/500mcg BD, salmeterol 50mcg BD and fluticasone propionate 500mcg BD, all delivered via the DISKUS®/ACCUHALER® inhaler, on mortality and morbidity of subjects with chronic obstructive pulmonary disease (COPD) over 3 years of treatment

Medicine or Vaccine (generic name)

fluticasone propionate/salmeterol

Sponsor Identification Number

SCO30003

Trial Registry Identification Number(#'s)

NCT00268216

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=SCO30003

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00268216

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An analysis-ready dataset is not available for this study.

Date Added to this Site

September 2013